MarketInOut Stock Screener Log In | Sign Up
 

Novartis AG ADR

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 10/23/2026
Novartis AG ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization297,025 mln
Float1,830 mln
Earnings Date10/27/2026

EPS

6.62
Strong

P / E

22.83
Premium valuation

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.57
Likely reliable

1-Year Forecast

154.65
Fairly priced

Relative Strength

85 / 100
Strongly outperforming

Business Description

Novartis is a Swiss pharmaceutical company founded in 1996 and based in Basel, with operations spanning markets around the world. The company develops and sells treatments across a wide range of serious health conditions, including heart disease, cancer, blood disorders, immune conditions, and neurological diseases. Its portfolio includes well-established medicines such as Entresto for heart failure, Cosentyx for inflammatory conditions, Kisqali for certain cancers, and Zolgensma for spinal muscular atrophy, among many others. Novartis also works with outside partners, including a collaboration with Alnylam Pharmaceuticals to bring Leqvio, a cholesterol-lowering therapy, to patients globally.

Key Fundamentals

EPS6.62
P/E22.83
ROE29.85
RPS29.64
ROIC12.08
ROA11.16
Interest Cover11.66
EBITDA, mln22,133
EV / EBITDA14.24
EV / EBIT18.61
Revenue, mln54,794
EV / Revenue5.75

Quote Details

Last 151.12
Change -5.15 (-3.3%)
Open 156.08
Volume 4,358,185
Turnover 658,608,896
Average Volume 1,862,291

Financial Ratios

Pre-Tax Profit Margin28
Leverage Ratio2.94
Current Ratio0.86
Price / Book6.46
Price / Cash Flow16.33
Price / Free Cash Flow17.40
Debt / Equity1.18
Price / Sales5.27
PEG Ratio2.11

Financial Strength

Altman Z-Score3.37
Piotroski F-Score 5 / 9
Beneish M-Score-2.57
Price to Intrinsic Value1.44
Price to Lynch Fair Value2.61
1-Year Target Price154.65
Shiller PE Ratio22.40
Short Ratio2.15
Short % of Float0.30

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.33% 57 / 100   
1 Month 5.26% 83 / 100   
2 Months 1.04% 63 / 100   
6 Months 3.88% 64 / 100   
1 Year 17.23% 74 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog